{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:36:47Z","timestamp":1791434207028,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Start-up grant from Chinese University of Hong Kong","award":["Ref. Nos. 4930991"],"award-info":[{"award-number":["Ref. Nos. 4930991"]}]},{"name":"Start-up grant from Chinese University of Hong Kong","award":["4930992"],"award-info":[{"award-number":["4930992"]}]},{"name":"General Research Fund","award":["Ref. Nos. 14120818"],"award-info":[{"award-number":["Ref. Nos. 14120818"]}]},{"name":"General Research Fund","award":["14104620"],"award-info":[{"award-number":["14104620"]}]},{"name":"General Research Fund","award":["24121622"],"award-info":[{"award-number":["24121622"]}]},{"name":"Health and Medical Research Fund, The Food and Health Bureau","award":["Ref. No. 06170546"],"award-info":[{"award-number":["Ref. No. 06170546"]}]},{"name":"Partnership Research Programme, Innovation Technology Commission","award":["Ref. No. PRP\/090\/20FX"],"award-info":[{"award-number":["Ref. No. PRP\/090\/20FX"]}]},{"name":"Area of Excellence, University Grants Committee","award":["Ref. No. AoE\/M-402\/20"],"award-info":[{"award-number":["Ref. No. AoE\/M-402\/20"]}]},{"name":"Center for Neuromusculoskeletal Restorative Medicine, Health@InnoHK program, Innovation Technology Commission, Hong Kong SAR","award":["Ref. No. CT1.1"],"award-info":[{"award-number":["Ref. No. CT1.1"]}]},{"DOI":"10.13039\/100010874","name":"American Society for Bone and Mineral Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan","award":["111-2320-B-039-070-MY3"],"award-info":[{"award-number":["111-2320-B-039-070-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High dosage of dexamethasone (Dex) is an effective treatment for multiple diseases; however, it is often associated with severe side effects including muscle atrophy, resulting in higher risk of falls and poorer life quality of patients. Cell therapy with mesenchymal stem cells (MSCs) holds promise for regenerative medicine. In this study, we aimed to investigate the therapeutic efficacy of systemic administration of adipose-derived mesenchymal stem cells (ADSCs) in mitigating the loss of muscle mass and strength in mouse model of DEX-induced muscle atrophy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>3-month-old female C57BL\/6 mice were treated with Dex (20\u00a0mg\/kg\u00a0body weight, i.p.) for 10\u00a0days to induce muscle atrophy, then subjected to intravenous injection of a single dose of ADSCs (<jats:inline-formula><jats:alternatives><jats:tex-math>$$1\\times {10}^{6}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mrow>\n                      <mml:mn>1<\/mml:mn>\n                      <mml:mo>\u00d7<\/mml:mo>\n                      <mml:msup>\n                        <mml:mrow>\n                          <mml:mn>10<\/mml:mn>\n                        <\/mml:mrow>\n                        <mml:mn>6<\/mml:mn>\n                      <\/mml:msup>\n                    <\/mml:mrow>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> cells\/kg\u00a0body\u00a0weight) or vehicle control. The mice were killed 7\u00a0days after ADSCs treatment. Body compositions were measured by animal DXA, gastrocnemius muscle was isolated for ex vivo muscle functional test, histological assessment and Western blot, while tibialis anterior muscles were isolated for RNA-sequencing and qPCR. For in vitro study, C2C12 myoblast cells were cultured under myogenic differentiation medium for 5\u00a0days following 100\u00a0<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\mu$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mi>\u03bc<\/mml:mi>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula>M Dex treatment with or without ADSC-conditioned medium for another 4\u00a0days. Samples were collected for qPCR analysis and Western blot analysis. Myotube morphology was measured by myosin heavy chain immunofluorescence staining.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ADSC treatment significantly increased body lean mass (10\u201320%), muscle wet weight (15\u201330%) and cross-sectional area (CSA)\u00a0(~\u200933%) in DEX-induced muscle atrophy mice model and down-regulated muscle atrophy-associated genes expression (45\u201365%). Hindlimb grip strength (~\u200937%) and forelimb ex vivo muscle contraction property were significantly improved (~\u200957%) in the treatment group. Significant increase in type I fibres (~\u200977%) was found after ADSC injection. RNA-sequencing results suggested that ERK1\/2 signalling pathway might be playing important role underlying the beneficial effect of ADSC treatment, which was confirmed by ERK1\/2 inhibitor both in vitro and in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ADSCs restore the pathogenesis of Dex-induced muscle atrophy with an increased number of type I fibres, stronger muscle strength, faster recovery rate and more anti-fatigue ability via ERK1\/2 signalling pathway. The inhibition of muscle atrophy-associated genes by ADSCs offered this treatment as an intervention option for muscle-associated diseases. Taken together, our findings suggested that adipose-derived mesenchymal stem cell therapy could be a new treatment option for patient with Dex-induced muscle atrophy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03418-0","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T17:01:39Z","timestamp":1691168499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1\/2 signalling pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Belle Yu-Hsuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Wei-Ting","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Ting","family":"Shiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicodemus","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Yu-Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Kuang-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Yuk-Wai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"3418_CR1","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1172\/JCI118264","volume":"96","author":"D Dardevet","year":"1995","unstructured":"Dardevet D, Sornet C, Taillandier D, Savary I, Attaix D, Grizard J. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J Clin Investig. 1995;96:2113\u20139.","journal-title":"J Clin Investig."},{"key":"3418_CR2","doi-asserted-by":"publisher","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","volume":"105","author":"F Vogel","year":"2020","unstructured":"Vogel F, Braun LT, Rubinstein G, Zopp S, K\u00fcnzel H, Strasding F, et al. Persisting muscle dysfunction in Cushing\u2019s syndrome despite biochemical remission. J Clin Endocrinol Metab. 2020;105:e4490\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3418_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/archneur.1970.00480200024002","volume":"22","author":"DE Pleasure","year":"1970","unstructured":"Pleasure DE, Walsh GO, Engel WK. Atrophy of skeletal muscle in patients with Cushing\u2019s syndrome. Arch Neurol. 1970;22:118\u201325. https:\/\/doi.org\/10.1001\/archneur.1970.00480200024002.","journal-title":"Arch Neurol"},{"key":"3418_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","volume":"50","author":"L Fardet","year":"2011","unstructured":"Fardet L, Petersen I, Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50:1982\u201390.","journal-title":"Rheumatology"},{"key":"3418_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s12098-008-0208-1","volume":"75","author":"P Gupta","year":"2008","unstructured":"Gupta P, Bhatia V. Corticosteroid physiology and principles of therapy. Indian J Pediat. 2008;75:1039\u201344.","journal-title":"Indian J Pediat"},{"key":"3418_CR6","unstructured":"Rathbun KM, Nguyen M, Singhal M. Addisonian Crisis. In: StatPearls Publishing; 2021."},{"key":"3418_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12020-017-1380-8","volume":"59","author":"V Camozzi","year":"2018","unstructured":"Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, et al. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison\u2019s disease on glucocorticoid and mineralocorticoid replacement therapy. Endocrine. 2018;59:319\u201329.","journal-title":"Endocrine"},{"key":"3418_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035273","volume":"7","author":"D Bloemberg","year":"2012","unstructured":"Bloemberg D, Quadrilatero J. Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS ONE. 2012;7: e35273.","journal-title":"PLoS ONE"},{"issue":"78","key":"3418_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/jappl.1995.78.2.629","volume":"1995","author":"PN Dekhuijzen","year":"1985","unstructured":"Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R, Decramer M. Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol. 1985;1995(78):629\u201337. https:\/\/doi.org\/10.1152\/jappl.1995.78.2.629.","journal-title":"J Appl Physiol"},{"key":"3418_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00000539-200008000-00017","volume":"91","author":"YS Shin","year":"2000","unstructured":"Shin YS, Fink H, Khiroya R, Ibebunjo C, Martyn J. Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression. Anesth Analg. 2000;91:322\u20138. https:\/\/doi.org\/10.1097\/00000539-200008000-00017.","journal-title":"Anesth Analg"},{"key":"3418_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008;197:1\u201310. https:\/\/doi.org\/10.1677\/JOE-07-0606.","journal-title":"J Endocrinol"},{"key":"3418_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jcsm.12315","volume":"9","author":"M Gueugneau","year":"2018","unstructured":"Gueugneau M, d\u2019Hose D, Barbe C, de Barsy M, Lause P, Maiter D, et al. Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy. J Cachexia Sarcopenia Muscle. 2018;9:929\u201346. https:\/\/doi.org\/10.1002\/jcsm.12315.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3418_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1210\/en.2016-1779","volume":"158","author":"AY Sato","year":"2017","unstructured":"Sato AY, Richardson D, Cregor M, Davis HM, Au ED, McAndrews K, et al. Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases. Endocrinology. 2017;158:664\u201377. https:\/\/doi.org\/10.1210\/en.2016-1779.","journal-title":"Endocrinology"},{"key":"3418_CR14","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76:3323\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"3418_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","volume":"52","author":"DE Rodr\u00edguez-Fuentes","year":"2021","unstructured":"Rodr\u00edguez-Fuentes DE, Fern\u00e1ndez-Garza LE, Samia-Meza JA, Barrera-Barrera SA, Caplan AI, Barrera-Salda\u00f1a HA. Mesenchymal stem cells current clinical applications: a systematic review. Arch Med Res. 2021;52:93\u2013101.","journal-title":"Arch Med Res"},{"key":"3418_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0922-1","volume":"9","author":"A Gorecka","year":"2018","unstructured":"Gorecka A, Salemi S, Haralampieva D, Moalli F, Stroka D, Candinas D, et al. Autologous transplantation of adipose-derived stem cells improves functional recovery of skeletal muscle without direct participation in new myofiber formation. Stem Cell Res Ther. 2018;9:1\u201312.","journal-title":"Stem Cell Res Ther"},{"key":"3418_CR17","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1634\/stemcells.2008-0043","volume":"26","author":"NM Vieira","year":"2008","unstructured":"Vieira NM, Bueno CR Jr, Brandalise V, Moraes LV, Zucconi E, Secco M, et al. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem cells. 2008;26:2391\u20138.","journal-title":"Stem cells"},{"key":"3418_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3727\/096368911X","volume":"21","author":"N Vieira","year":"2012","unstructured":"Vieira N, Valadares M, Zucconi E, Secco M, Junior CB, Brandalise V, et al. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transplant. 2012;21:1407\u201317.","journal-title":"Cell Transplant"},{"key":"3418_CR19","doi-asserted-by":"publisher","first-page":"eabg0088","DOI":"10.1126\/sciadv.abg0088","volume":"7","author":"JT Seto","year":"2021","unstructured":"Seto JT, Roeszler KN, Meehan LR, Wood HD, Tiong C, Bek L, et al. ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone. Sci Adv. 2021;7:eabg0088.","journal-title":"Sci Adv"},{"key":"3418_CR20","doi-asserted-by":"crossref","unstructured":"Lee C-W, Chen Y-F, Hsiao AW-T, Wang AY-F, Shen OY-J, Wang BY-H, et al. Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells. J Adv Res. 2022; 39:73\u201388.","DOI":"10.1016\/j.jare.2021.11.003"},{"key":"3418_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1535-7163.MCT-10-0631","volume":"10","author":"F Marampon","year":"2011","unstructured":"Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, Fardella C, et al. MEK\/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Mol Cancer Ther. 2011;10:159\u201368.","journal-title":"Mol Cancer Ther"},{"key":"3418_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/1535-7163.MCT-08-0570","volume":"8","author":"F Marampon","year":"2009","unstructured":"Marampon F, Bossi G, Ciccarelli C, Di Rocco A, Sacchi A, Pestell RG, et al. MEK\/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Mol Cancer Ther. 2009;8:543\u201351.","journal-title":"Mol Cancer Ther"},{"key":"3418_CR23","doi-asserted-by":"crossref","unstructured":"Pan B, Zhong P, Sun D, Liu Q-s. Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci. 2011;31:11244\u201355.","DOI":"10.1523\/JNEUROSCI.1040-11.2011"},{"key":"3418_CR24","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.4049\/jimmunol.172.11.7053","volume":"172","author":"W Duan","year":"2004","unstructured":"Duan W, Chan JH, Wong CH, Leung BP, Wong WF. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol. 2004;172:7053\u20139.","journal-title":"J Immunol"},{"key":"3418_CR25","doi-asserted-by":"publisher","first-page":"E160","DOI":"10.1152\/ajpendo.00325.2015","volume":"310","author":"S Miyatake","year":"2016","unstructured":"Miyatake S, Bilan PJ, Pillon NJ, Klip A. Contracting C2C12 myotubes release CCL2 in an NF-\u03baB-dependent manner to induce monocyte chemoattraction. Am J Physiol Endocrinol Metab. 2016;310:E160\u201370.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3418_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/MCB.00666-09","volume":"30","author":"S Clavel","year":"2010","unstructured":"Clavel S, Siffroi-Fernandez S, Coldefy AS, Boulukos K, Pisani DF, D\u00e9rijard B. Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells. Mol Cell Biol. 2010;30:470\u201380.","journal-title":"Mol Cell Biol"},{"key":"3418_CR27","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/hmg\/ddw090","volume":"25","author":"M Chatzifrangkeskou","year":"2016","unstructured":"Chatzifrangkeskou M, Le Dour C, Wu W, Morrow JP, Joseph LC, Beuvin M, et al. ERK1\/2 directly acts on CTGF\/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A\/C gene. Hum Mol Genet. 2016;25:2220\u201333.","journal-title":"Hum Mol Genet"},{"key":"3418_CR28","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1074\/jbc.RA118.004977","volume":"294","author":"NV Bhanu","year":"2019","unstructured":"Bhanu NV, Sidoli S, Yuan Z-F, Molden RC, Garcia BA. Regulation of proline-directed kinases and the trans-histone code H3K9me3\/H4K20me3 during human myogenesis. J Biol Chem. 2019;294:8296\u2013308.","journal-title":"J Biol Chem"},{"key":"3418_CR29","doi-asserted-by":"publisher","first-page":"C658","DOI":"10.1152\/ajpcell.00078.2002","volume":"284","author":"C Cabane","year":"2003","unstructured":"Cabane C, Englaro W, Yeow K, Ragno M, D\u00e9rijard B. Regulation of C2C12 myogenic terminal differentiation by MKK3\/p38\u03b1 pathway. Am J Physiol Cell Physiol. 2003;284:C658\u201366.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3418_CR30","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41418-018-0063-1","volume":"25","author":"S-J Xie","year":"2018","unstructured":"Xie S-J, Li J-H, Chen H-F, Tan Y-Y, Liu S-R, Zhang Y, et al. Inhibition of the JNK\/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development. Cell Death Differ. 2018;25:1581\u201397.","journal-title":"Cell Death Differ"},{"key":"3418_CR31","doi-asserted-by":"crossref","unstructured":"Dougherty JP, Springer DA, Gershengorn MC. The treadmill fatigue test: a simple, high-throughput assay of fatigue-like behavior for the mouse. JoVE. 2016;e54052.","DOI":"10.3791\/54052"},{"key":"3418_CR32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1152\/japplphysiol.00085.2007","volume":"103","author":"HF Kramer","year":"2007","unstructured":"Kramer HF, Goodyear LJ. Exercise, MAPK, and NF-\u03baB signaling in skeletal muscle. J Appl Physiol. 2007;103:388\u201395.","journal-title":"J Appl Physiol"},{"key":"3418_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/ijms21031111","volume":"21","author":"H Geng","year":"2020","unstructured":"Geng H, Song Q, Cheng Y, Li H, Yang R, Liu S, et al. MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting IGF1R and INSR. Int J Mol Sci. 2020;21:1111.","journal-title":"Int J Mol Sci"},{"key":"3418_CR34","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.3892\/mmr.2017.6443","volume":"15","author":"MK Lee","year":"2017","unstructured":"Lee MK, Kim YM, Kim IH, Choi YH, Nam TJ. Pyropia yezoensis peptide PYP1-5 protects against dexamethasone-induced muscle atrophy through the downregulation of atrogin1\/MAFbx and MuRF1 in mouse C2C12 myotubes. Mol Med Rep. 2017;15:3507\u201314.","journal-title":"Mol Med Rep"},{"key":"3418_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/sports9090127","volume":"9","author":"DL Plotkin","year":"2021","unstructured":"Plotkin DL, Roberts MD, Haun CT, Schoenfeld BJ. Muscle fiber type transitions with exercise training: Shifting perspectives. Sports. 2021;9:127.","journal-title":"Sports"},{"key":"3418_CR36","first-page":"1","volume":"5","author":"M Kim","year":"2015","unstructured":"Kim M, Kim Y, Kim Z, Heo S, Kim S, Hwang J, et al. Mesenchymal stem cells suppress muscle atrophy induced by hindlimb suspension. J Stem Cell Res Ther. 2015;5:1\u201310.","journal-title":"J Stem Cell Res Ther"},{"key":"3418_CR37","doi-asserted-by":"publisher","first-page":"C215","DOI":"10.1152\/ajpcell.00384.2021","volume":"323","author":"Y Nishimura","year":"2022","unstructured":"Nishimura Y, Chunthorng-Orn J, Lord S, Musa I, Dawson P, Holm L, et al. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells. Am J Physiol Cell Physiol. 2022;323:C215\u201325.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3418_CR38","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","volume":"24","author":"EL Greer","year":"2005","unstructured":"Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24:7410\u201325.","journal-title":"Oncogene"},{"key":"3418_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7670","volume":"6","author":"G Milan","year":"2015","unstructured":"Milan G, Romanello V, Pescatore F, Armani A, Paik J-H, Frasson L, et al. Regulation of autophagy and the ubiquitin\u2013proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun. 2015;6:1\u201314.","journal-title":"Nat Commun"},{"key":"3418_CR40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","volume":"6","author":"J Zhao","year":"2007","unstructured":"Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, et al. FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007;6:472\u201383.","journal-title":"Cell Metab"},{"key":"3418_CR41","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00125-013-2863-7","volume":"56","author":"G Kaiser","year":"2013","unstructured":"Kaiser G, Gerst F, Michael D, Berchtold S, Friedrich B, Strutz-Seebohm N, et al. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro. Diabetologia. 2013;56:1587\u201395.","journal-title":"Diabetologia"},{"key":"3418_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcsm.12677","volume":"12","author":"T Cid-D\u00edaz","year":"2021","unstructured":"Cid-D\u00edaz T, Leal-L\u00f3pez S, Fern\u00e1ndez-Barreiro F, Gonz\u00e1lez-S\u00e1nchez J, Santos-Zas I, Andrade-Bulos LJ, et al. Obestatin signalling counteracts glucocorticoid-induced skeletal muscle atrophy via NEDD4\/KLF15 axis. J Cachexia Sarcopenia Muscle. 2021;12:493\u2013505.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3418_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1152\/jappl.2001.91.2.693","volume":"91","author":"LC Martineau","year":"2001","unstructured":"Martineau LC, Gardiner PF. Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol. 2001;91:693\u2013702.","journal-title":"J Appl Physiol"},{"key":"3418_CR44","doi-asserted-by":"crossref","unstructured":"Qiu Y, Yu J, Ji X, Yu H, Xue M, Zhang F, et al. Ileal FXR-FGF15\/19 signaling activation improves skeletal muscle loss in aged mice. Mech Ageing Dev. 2022;111630.","DOI":"10.1016\/j.mad.2022.111630"},{"key":"3418_CR45","doi-asserted-by":"crossref","unstructured":"Boyer JG, Prasad V, Song T, Lee D, Fu X, Grimes KM, et al. ERK1\/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity. JCI insight. 2019;4:","DOI":"10.1172\/jci.insight.127356"},{"key":"3418_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musia\u0142-Wysocka","year":"2019","unstructured":"Musia\u0142-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 2019;28:801\u201312.","journal-title":"Cell Transplant"},{"key":"3418_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1213-1","volume":"10","author":"R Mitchell","year":"2019","unstructured":"Mitchell R, Mellows B, Sheard J, Antonioli M, Kretz O, Chambers D, et al. Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins. Stem Cell Res Ther. 2019;10:1\u201319.","journal-title":"Stem Cell Res Ther"},{"key":"3418_CR48","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.","journal-title":"J Extracell Vesicles"},{"key":"3418_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00478-0","volume":"7","author":"J-Y Chi","year":"2021","unstructured":"Chi J-Y, Hsiao Y-W, Liu H-L, Fan X-J, Wan X-B, Liu T-L, et al. Fibroblast CEBPD\/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4. Cell Death Discov. 2021;7:1\u201316.","journal-title":"Cell Death Discov"},{"key":"3418_CR50","doi-asserted-by":"publisher","first-page":"165386","DOI":"10.1016\/j.bbadis.2019.01.012","volume":"1866","author":"AR Lorenzon-Ojea","year":"2020","unstructured":"Lorenzon-Ojea AR, Yung HW, Burton GJ, Bevilacqua E. The potential contribution of stromal cell-derived factor 2 (SDF2) in endoplasmic reticulum stress response in severe preeclampsia and labor-onset. Biochimica et Biophysica Acta (BBA) Mol Basis Disease. 2020;1866:165386.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Disease."},{"key":"3418_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbi.2021.03.011","volume":"94","author":"G Amodeo","year":"2021","unstructured":"Amodeo G, Niada S, Moschetti G, Franchi S, Savadori P, Brini AT, et al. Secretome of human adipose-derived mesenchymal stem cell relieves pain and neuroinflammation independently of the route of administration in experimental osteoarthritis. Brain Behav Immun. 2021;94:29\u201340.","journal-title":"Brain Behav Immun"},{"key":"3418_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fbioe.2020.00090","volume":"8","author":"MEF Palam\u00e0","year":"2020","unstructured":"Palam\u00e0 MEF, Shaw GM, Carluccio S, Reverberi D, Sercia L, Persano L, et al. The secretome derived from mesenchymal stromal cells cultured in a xeno-free medium promotes human cartilage recovery in vitro. Front Bioeng Biotechnol. 2020;8:90.","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03418-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03418-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T17:20:31Z","timestamp":1700587231000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03418-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03418-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The approved animal ethic by the Animal Experimentation Ethics Committee (AEEC) of The Chinese University of Hong Kong (Title: Therapeutic applications of exosomes from mesenchymal stem cells for sarcopenia; No.18\/256\/MIS-5-B; Date of approval: 10th, April, 2019) is proved in the Ethics approval session in the manuscript. All animal research followed the International Guiding Principles for Biomedical Research Involving Animals, ARRIVE guideline and The Hong Kong Code of Practice for Care and Use of Animals for Experimental Purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Oscar Kuang-Sheng Lee is a member of the editorial board of Stem Cell Research & Therapy, and he was not involved in the peer review, or decision-making of this article. All other authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}